Bank of New York Mellon
BIOA

Bank of New York Mellon’s BioAge Labs BIOA Stock Holding History

Bank of New York Mellon’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.63M Buy
107,332
+31,764
+42% +$574K ﹤0.01% 2796
2026
Q1 		$1.32M Buy
75,568
+14,008
+23% +$270K ﹤0.01% 3045
2025
Q4 		$814K Buy
61,560
+3,562
+6% +$31.6K ﹤0.01% 3351
2025
Q3 		$341K Buy
57,998
+4,028
+7% +$18.9K ﹤0.01% 3809
2025
Q2 		$223K Buy
53,970
+32,436
+151% +$131K ﹤0.01% 3939
2025
Q1 		$81K Buy
21,534
+6,849
+47% +$31.7K ﹤0.01% 4025
2024
Q4 		$85K Buy
+14,685
New +$253K ﹤0.01% 4042

Other funds holding BIOA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
ACM
Alessandra Capital Management Torrance, California $141M AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon's BIOA Position: Q2 2026 in Review

Bank of New York Mellon increased its BioAge Labs (BIOA) stake by 42% in Q2 2026, buying an estimated $574K and bringing the position to 107,332 shares worth $2.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2796.

Bank of New York Mellon first reported a position in BIOA in Q4 2024 and has held it in 7 quarters since. 49 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Bank of New York Mellon held 107,332 shares of BioAge Labs worth $2.63M as of Q2 2026.
  • Bank of New York Mellon bought 31,764 BioAge Labs shares in Q2 2026, an estimated $574K.
  • BioAge Labs made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2796 holding.
  • Bank of New York Mellon first reported a position in BioAge Labs in Q4 2024 and has held it in 7 quarters since.
  • 49 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.